← Open Payments lookup

ALEXIA MUNTER: Open Payments

NPI 1407384902 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,199 in 63 payments from 16 companies in 2025. Trend: 2023 $1,107 · 2024 $1,712 · 2025 $1,199

Food & beverage: $1,199
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$238
GlaxoSmithKline, LLC.12$212
Regeneron Healthcare Solutions, Inc.8$178
ARS Pharmaceuticals Operations, Inc.5$98
Novartis Pharmaceuticals Corporation4$81
Genentech USA, Inc.4$75
GENZYME CORPORATION3$60
Grifols USA, LLC3$57
Takeda Pharmaceuticals U.S.A., Inc.3$54
Optinose US, Inc.2$33

Products named: DUPIXENT, TRELEGY ELLIPTA, NEFFY, AIRSUPRA, NUCALA, Xolair, Xembify, TEZSPIRE.

Industry payments across MO — which companies pay providers there.